The bill would prohibit the sale of foods that contain poppy seeds above federally determined contamination levels of morphine, codeine, and other alkaloids. It requires the Department of Health and Human Services to issue a proposed rule within one year establishing those levels and to finalize the rule within two years.
Once finalized, seeds that exceed the levels would be deemed adulterated under the Federal Food, Drug, and Cosmetic Act, triggering federal regulation and enforcement. The act also preserves the continued regulation of contaminated seeds under the controlled substances framework, ensuring that adulterated seeds remain subject to existing controls.
At a Glance
What It Does
Requires HHS to set contamination levels for morphine, codeine, and other alkaloids in poppy seeds within one year (proposed rule) and finalizes the rule within two years; seeds with contamination above those levels become adulterated under the FD&C Act.
Who It Affects
Food manufacturers, distributors, and retailers that use poppy seeds in interstate commerce; poppy seed importers and suppliers; regulatory agencies enforcing food safety.
Why It Matters
Creates a health-protective standard for poppy seeds, reduces risk of opiate exposure from contaminated seeds, and anchors enforcement in FD&C Act while aligning with CSA controls.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The Stephen Hacala Poppy Seed Safety Act addresses a public health risk posed by contaminated poppy seeds. It frames unsafe seeds as adulterants that cannot be sold in interstate commerce once contamination levels are established.
The bill begins with findings about real-world harms—from deaths linked to contaminated seeds to opioid exposure in hospital settings—and then sets up a rulemaking process to create measurable contamination thresholds for morphine, codeine, and related alkaloids. The overarching aim is to prevent unsafe seeds from entering the food supply and to give federal agencies clearer enforcement authority.
Key mechanics include a two-step rulemaking timetable: a proposed rule within one year and a final rule within two years. After the rule takes effect, seeds that exceed the established contamination levels would be treated as adulterated under the Federal Food, Drug, and Cosmetic Act, enabling federal regulators to remove unsafe products from interstate commerce.
The bill also clarifies that contaminated poppy seeds remain under regulation if they are linked to opiate alkaloids, ensuring alignment with the Controlled Substances Act. This creates a unified federal framework that covers both public health protections and existing drug-control regimes.In practice, the act targets the supply chain from seed suppliers to food manufacturers and retailers.
It signals to industry players that establishing robust testing and supplier controls will be essential to continued eligibility for interstate sales, while giving enforcers a clear basis to act against unsafe products.
The Five Things You Need to Know
The bill requires HHS to issue a proposed rule within 1 year establishing contamination levels for morphine, codeine, and related alkaloids in poppy seeds.
Within 2 years, the rule must be finalized; seeds above the levels will be deemed adulterated under the FD&C Act.
Poppy seeds contaminated by morphine, codeine, or designated alkaloids remain subject to regulation under the Controlled Substances Act.
The measure applies to all foods and ingredients sold in interstate commerce that contain poppy seeds.
The act anchors poppy seed safety into federal law, creating a formal standard and enforcement pathway.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short Title
Cites the act as the Stephen Hacala Poppy Seed Safety Act, establishing the formal name by which the bill will be known if enacted.
Findings and Purpose
Documents Congress’s rationale: harms from contaminated poppy seeds, the need to establish contamination levels for morphine and other alkaloids, and the objective of deeming seeds adulterated once thresholds are exceeded. This section frames the public health intent and sets the policy direction for the rulemaking to follow.
Unsafe Poppy Seeds as Adulterants; Rulemaking
Requires the Secretary of Health and Human Services to publish a proposed rule within 1 year establishing contamination levels for morphine, codeine, and other alkaloids in poppy seeds and to finalize the rule within 2 years. After finalization, poppy seeds meeting or exceeding those levels would be adulterated under the FD&C Act, enabling federal enforcement against noncompliant products.
CSA Regulation of Contaminated Seeds
Clarifies that nothing in the act exempts contaminated poppy seeds from regulation under the Controlled Substances Act. The provision preserves existing CSA controls on seeds contaminated with opium alkaloids, ensuring alignment across food safety and drug-control regimes.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Consumers and households that purchase foods containing poppy seeds, who gain protection from exposure to morphine and other alkaloids.
- Food manufacturers and brands that source poppy seeds will benefit from a clear standard and reduced liability for uncertain contamination.
- Poppy seed suppliers and producers who maintain low-contamination lots can differentiate themselves through compliance and quality controls.
- Distributors and retailers in interstate commerce gain a predictable regulatory framework for product safety and labeling.
- Public health regulators (FDA/HHHS) obtain explicit authority to regulate adulterated seeds within a formal rulemaking process.
Who Bears the Cost
- Seed suppliers with higher contamination may incur remediation or supply-switching costs as they come into compliance.
- Food manufacturers and retailers may face costs for testing, supplier audits, and potential product recalls to meet the new standard.
- Regulatory agencies will need resources to implement, monitor, and enforce the rule; this could entail increased staffing and testing programs.
- Importers of poppy seeds may incur additional compliance costs to verify supply chain integrity.
- Small businesses in the supply chain could be disproportionately affected by testing and certification requirements.
Key Issues
The Core Tension
The central dilemma is balancing a rigorous public health standard for poppy seeds with the practical realities of supply chains, testing capacity, and enforcement resources. On one hand, stricter thresholds reduce health risks; on the other hand, they risk supply disruption or higher prices if compliance is costly or technically challenging.
The bill advances a health-protective standard, but its success hinges on the practical feasibility of testing and enforcing contamination levels across a global supply chain. Establishing robust, scientifically valid thresholds will require substantial data, validated testing methods, and clear enforcement guidance.
There is a potential cost impedance: smaller suppliers or importers may face higher compliance expenses, which could affect product availability or pricing. The interaction between the proposed FD&C Act framework and the existing CSA controls adds regulatory complexity and may require careful coordination to avoid gaps or duplicative requirements.
The timing and scope of rulemaking will determine how quickly the market can adapt without disrupting interstate commerce.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.